David Y. Liu - Feb 28, 2022 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Scientific Officer
Signature
/s/ Donald A. Kalkofen, Attorney-in-Fact for David Y. Liu
Stock symbol
PTGX
Transactions as of
Feb 28, 2022
Transactions value $
-$51,449
Form type
4
Date filed
3/2/2022, 07:38 PM
Previous filing
Feb 17, 2022
Next filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Tax liability -$51.4K -2.12K -3.09% $24.28 66.5K Feb 28, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 6,125 vested restricted stock units on February 28, 2022.